Disruptive Capital Finance
Private equity investment vehicle and family office of the Truell family, chaired by Edi Truell; makes opportunistic investments across sectors and stages.
USEFUL FOR Business owners seeking a long-term partner · Co-investors
Family & background
- FAMILY
- Truell
- HEADQUARTERS
- London, United Kingdom
- OFFICES
- St Peter Port, Guernsey
- FOUNDED
- 2009
Investment approach
- ROUTES
- Companies (own capital)
- STRATEGIES
- Private equityDirect investmentsImpact
Overview
Disruptive Capital is the private equity investment vehicle and family office of the Truell family, which holds most of its assets there, according to a 2019 trade report. Its operating entity, Disruptive Capital GP Limited, is a Guernsey company licensed by the Guernsey Financial Services Commission and part-owned by the Truell Conservation Foundation, a UK charity founded by Edi and Danny Truell. It makes opportunistic investments in market dislocations and complex situations; holdings include Atlantic SuperConnection, Pension Insurance Corporation, Telent, essDocs, ViroCell and Alpine hospitality assets in Switzerland.
Investment thesis
Unlocks value from market dislocations and complex opportunities, investing across a broad range of sectors and stages in disruptive companies and sustainable business models.
Holdings & investments (12)
- Atlantic SuperConnectionClimate & Energy
- Brooklyn ImmunoTherapeuticsBiotech & Life Sciences
- REG TechnologiesSoftware & SaaS
- Pension Insurance CorporationFintech
- TelentIndustrial & Manufacturing
- essDocsSoftware & SaaS
- Ptarmigan Health DestinationsReal Estate & PropTech
- ViroCell BiologicsBiotech & Life Sciences
- Disruptive Capital Acquisition Company
- The Kurhaus ArollaReal Estate & PropTech
- Careful SystemsHealthTech
- Global Interconnection GroupClimate & Energy
People
Frequently asked questions
Disruptive Capital Finance is a single family office based in London, the United Kingdom, founded in 2009.
Disruptive Capital Finance invests on behalf of the Truell family.
Disruptive Capital Finance invests its own capital into companies. Its stated asset mix includes private equity, direct investments and impact.
Disruptive Capital Finance invests in Climate & Energy, Biotech & Life Sciences, Fintech, Software & SaaS and Real Estate & PropTech.
Key people at Disruptive Capital Finance include Edi Truell (Chairman), Cédriane de Boucaud (Director), Jane Dickinson (Senior Advisor) and Jasper Mohan (Investment Associate).
Disruptive Capital Finance's holdings and investments include Atlantic SuperConnection, Brooklyn ImmunoTherapeutics, REG Technologies, Pension Insurance Corporation, Telent, essDocs, Ptarmigan Health Destinations and ViroCell Biologics, among others.
The most recent publicly reported investment by Disruptive Capital Finance is REG Technologies (Follow-on equity in GBP2.4m round), announced in May 2019.